newsfilter
← Latest News
GlobeNewswire·

Jounce Therapeutics to Participate in Fireside Chat at the Raymond James Human Health Innovation Conference

CAMBRIDGE, Mass., June 14, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Richard Murra